Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis

Annals of Surgery

Volumn 254, Issue 1, 2011, Pages 48-54

  Mertz, Dominik ^a,b   Johnstone, Jennie ^a,b   Loeb, Mark ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CLAVULANATE POTASSIUM PLUS TICARCILLIN; FLUCLOXACILLIN; GENTAMICIN; NETILMICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CINAHL; EMBASE; HUMAN; INFECTION; INFORMATION RETRIEVAL; LONG TERM CARE; MEDLINE; META ANALYSIS; MORTALITY; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SHORT COURSE THERAPY; STERNAL SURGICAL SITE INFECTION; SYSTEMATIC REVIEW; TREATMENT DURATION;

ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STERNOTOMY; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 79959497065     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318214b7e4     Document Type: Review

References (47)

1. Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004;77(2):676-683. (Pubitemid 38186531)
2. Crabtree TD, Codd JE, Fraser VJ, et al. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg. 2004;16(1): 53-61. (Pubitemid 38714760)
3. Olsen MA, Lock-Buckley P, Hopkins D, et al. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg. 2002;124(1):136-145.
4. Trussell J, Gerkin R, Coates B, et al. Impact of a patient care pathway protocol on surgical site infection rates in cardiothoracic surgery patients. Am J Surg. 2008;196(6):883-889; discussion 889.
5. Fakih MG, Sharma M, Khatib R, et al. Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness. Infect Control Hosp Epidemiol. 2007;28(6):655-660. (Pubitemid 46954749)
6. Edwards FH, Engelman RM, Houck P, et al. The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg. 2006;81(1):397-404. (Pubitemid 41815461)
7. Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007;83(4):1569-1576.
8. Graf K, Ott E, Vonberg RP, et al. Economic aspects of deep sternal wound infections. Eur J Cardiothorac Surg. 2009.
9. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm. 1999;56(18):1839-1888.
10. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38(12):1706-1715. (Pubitemid 38781662)
11. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994;18(3):422-427. (Pubitemid 24086316)
12. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004;44(5):e213-310.
13. Gilbert DN, Moellering Jr RC. Eliopoulos GM, et al. The Sanford Guide To Antimicrobial Therapy. 39th Edition, 2009 Antimicrobial Therapy Sperryville, VA.
14. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250-278; quiz 279-280.
15. Page CP, Bohnen JM, Fletcher JR, et al. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg. 1993;128(1):79-88. (Pubitemid 23027028)
16. Scher KS. Studies on the duration of antibiotic administration for surgical prophylaxis. Am Surg. 1997;63(1):59-62. (Pubitemid 27020429)
17. Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916-2921. (Pubitemid 30415881)
18. Terpstra S, Noordhoek GT, Voesten HG, et al. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect. 1999;43(3):195-202.
19. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2002;46(6):1619-1628. (Pubitemid 34535173)
20. Braxton JH, Marrin CA, McGrath PD, et al. 10-year follow-up of patients with and without mediastinitis. Semin Thorac Cardiovasc Surg. 2004;16(1):70-76. (Pubitemid 38714762)
21. Tang GH, Maganti M, Weisel RD, et al. Prevention and management of deep sternal wound infection. Semin Thorac Cardiovasc Surg. 2004;16(1):62-69. (Pubitemid 38714761)
22. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg. 1992;104(3):590-599.
23. Conte JE, Cohen SN, Roe BB, et al. Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens. Ann Intern Med. 1972; 943-949.
24. Austin TW, Coles JC, Burnett R, et al. Aortocoronary bypass procedures and sternotomy infections: a study of antistaphylococcal prophylaxis. Can J Surg. 1980;23(5):483-485. (Pubitemid 10005603)
25. Kriaras I, Michalopoulos A, Turina M, et al. Evolution of antimicrobial prophylaxis in cardiovascular surgery. Eur J Cardiothorac Surg. 2000;18(4): 440-446.
26. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140(2):174-182. (Pubitemid 40229109)
27. Lehot JJ, Helou S, Bastien O. Survey of antibiotic prophylaxis in cardiac surgery. Eur J Anaesthesiol. 2003;20(2):166-167. (Pubitemid 36222047)
28. Esposito S, Noviello S, Vanasia A, et al. Ceftriaxone versus other antibiotics for surgical prophylaxis: a meta-analysis. Clin Drug Investig. 2004;24(1): 29-39. (Pubitemid 38197750)
29. Bolon MK, Morlote M, Weber SG, et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004;38(10):1357-1363. (Pubitemid 38668578)
30. Garey KW, Lai D, Dao-Tran TK, et al. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008;52(2): 446-451. (Pubitemid 351170812)
31. Saginur R, Croteau D, Bergeron MG. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. J Thorac Cardiovasc Surg. 2000;120(6):1120-1130.
32. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.
33. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560. (Pubitemid 37088507)
34. Beam T, Raab T, Spooner J, et al. Single-dose antimicrobial prophylaxis in open heart surgery. Eur J Clin Microbiol. 1984;3(6):598-604.
35. Beam TR, Raab TA, Spooner JA. Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery. Am J Surg. 1984;148 (4 A):8-14. (Pubitemid 15207101)
36. Tamayo E, Gualis J, Florez S, et al. Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery. J Thorac Cardiovasc Surg. 2008;136(6):1522-1527.
37. Niederhauser U, Vogt M, Vogt P, et al. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovas Surg. 1997;114(2):162-168. (Pubitemid 27364204)
38. Horan T, Gaynes R. Hospital Epidemiology and Infection Control. In Mayhall C, ed. Philadelphia: Lippincott Williams & Wilkins, 2004:1659-1702.
39. Nooyen SMH, Overbeek BP, Brutel De La Riviere A, et al. Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting. Eur J Clin Microbiol Infect Dis. 1994;13(12):1033-1037.
40. Badel P, Schmuziger M. [Anti-infection prophylaxis in cardiac surgery: comparison of single-dose ceftriaxone and cefamandole in repeat doses]. Schweiz Rundsch Med Prax. 1989;78(22):643-645. (Pubitemid 19132942)
41. Kriaras I, Michalopoulos A, Michalis A, et al. Antibiotic prophylaxis in cardiac surgery. J Cardiovasc Surg. 1997;38(6):605-610. (Pubitemid 28040716)
42. Sisto T, Laurikka J, Tarkka MR. Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery. Scand J Thorac Cardiovasc Surg. 1994;28(3-4):143-148.
43. Salminen US, Viljanen TUT, Valtonen VV, et al. Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery. J Antimicrob Chemother. 1999;44(2):287-290. (Pubitemid 29389294)
44. Hall JC, Christiansen K, Carter MJ, et al. Antibiotic prophylaxis in cardiac operations. Ann Thorac Surg. 1993;56(4):916-922. (Pubitemid 23316073)
45. Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2-22.
46. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ. 2006;333(7562):281.
47. Shorr AF. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med. 2009;37(4): 1463-1469.